Nigeria vs Sur: The number of people with susceptibility test result for rifampicin
Nigeria
117,519
in 2021
Sur
67
in 2021
Nigeria rank
5th
Sur rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Nigeria
- Sur
How they compare
Nigeria currently reports 117,519 against 67 in Sur, a difference of 117,452.
That makes Nigeria's figure about 1,754.0 times Sur's.
Across all 5 years both countries report, Nigeria has been ahead every year.
Nigeria ranks 5th and Sur ranks 2nd of 155 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nigeria | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37,878 | 81.33 | 37,796 | Nigeria |
| 2020s | 91,529 | 66.5 | 91,462 | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nigeria or Sur?
- Nigeria, at 117,519 against 67 in Sur as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nigeria and Sur?
- 117,452, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and Sur?
- 5 years are reported by both, from 2017 to 2021.
- How do Nigeria and Sur rank globally for the number of people with susceptibility test result for rifampicin?
- Nigeria ranks 5th and Sur ranks 2nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.